MDCXW
Medicus Pharma Ltd. WarrantNASDAQ
Key Statistics
Market Cap
—
P/E Ratio
—
EPS
—
Beta
-0.04
52W High
$4.10
52W Low
$0.45
50-Day MA
$2.50
200-Day MA
$2.50
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Medicus Pharma Ltd. Warrant
Medicus Pharma Ltd. (MDCXW) is a dynamic pharmaceutical company dedicated to the development, manufacturing, and marketing of innovative drug therapies that address pressing health challenges. With a robust pipeline supported by rigorous research and development, Medicus Pharma utilizes cutting-edge technologies to enhance patient outcomes while adhering to high regulatory standards. As a significant player in the pharmaceutical landscape, the company’s strategic emphasis on pioneering healthcare solutions poises it to effectively respond to the evolving medical needs of the market, ultimately delivering long-term value to its investors.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | — |
| Operating Margin | 0.00% |
| Return on Equity | -2981.00% |
| Return on Assets | -204.10% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $-0.00 |
| Price-to-Book | — |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | 0 |
| Float | $32.82M |
| % Insiders | 0.00% |
| % Institutions | 0.00% |
Data last updated: 4/8/2026